Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Four peptide hormones' specific decrease (up to 97%) of human prostate carcinoma cells.

B A Vesely1, A A Alli, S J Song

  • 1University of South Florida Cardiac Hormone Center and James A. Haley Veterans Medical Center, Tampa, FL 33612, USA.

European Journal of Clinical Investigation
|November 5, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bladder health and the urogenital microbiome in community-dwelling adult females.

mSystems·2025
Same author

[Clinicopathological features of <i>Helicobacter pylori</i>-negative early gastric cancer].

Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences·2023
Same author

[Clinicopathological features of verrucous type dysplasia of esophagus].

Zhonghua bing li xue za zhi = Chinese journal of pathology·2022
Same author

[Changes of cytokines in the aqueous humor of neovascular glaucoma at the angle-closure stage].

[Zhonghua yan ke za zhi] Chinese journal of ophthalmology·2022
Same author

Kinetics of <i>HTT</i> lowering in brain of YAC 128 mice following single and repetitive intranasal dosing of siRNA packaged in chitosan-based nanoparticle.

Journal of drug delivery science and technology·2021
Same author

[Pathological characteristics of colorectal adenoma with submucosal pseudoinvasion].

Zhonghua bing li xue za zhi = Chinese journal of pathology·2021
Same journal

Pacemaker Status and 5-Year Mortality After TAVI: A Sex-Specific Analysis.

European journal of clinical investigation·2026
Same journal

Causal Effects of Time-Varying Treatments: The G-Formula.

European journal of clinical investigation·2026
Same journal

Improving Scientific Research: Renegotiated Principles of Science, Proposals, Failures, and Successes.

European journal of clinical investigation·2026
Same journal

Beta-Blockers After Myocardial Infarction With Preserved and Mildly Reduced Ejection Fraction: A Meta-Analysis With Trial Sequential Analysis.

European journal of clinical investigation·2026
Same journal

Prognostic Role of Serum Albumin Levels in Elderly Patients With Non-Valvular Atrial Fibrillation.

European journal of clinical investigation·2026
Same journal

Circulating Human Epididymis Protein 4 Predicts 10-Year Mortality and Major Adverse Cardiovascular Events in Patients With Peripheral Artery Disease.

European journal of clinical investigation·2026
See all related articles

Natriuretic peptides show potent anticancer effects against prostate cancer cells. These peptide hormones effectively eliminate up to 97% of cancer cells within 24 hours, offering a promising new avenue for prostate cancer treatment.

Area of Science:

  • Oncology
  • Endocrinology
  • Molecular Biology

Background:

  • Prostate cancer mortality remains a significant issue.
  • Natriuretic peptides exhibit anticancer effects in other adenocarcinomas.
  • The efficacy of natriuretic peptides in prostate cancer was previously undetermined.

Purpose of the Study:

  • To evaluate the specific anticancer effects of four peptide hormones in human prostate adenocarcinomas.
  • To determine if these peptide hormones could reduce prostate cancer cell viability and DNA synthesis.

Main Methods:

  • Human prostate adenocarcinoma cells were treated with varying concentrations of four peptide hormones.
  • Cell viability and DNA synthesis were measured.
  • Western blotting was used to detect natriuretic peptide receptors (NPRs).

Related Experiment Videos

Main Results:

  • A dose-dependent decrease in prostate cancer cells was observed with increasing peptide hormone concentrations.
  • Vessel dilator, long-acting natriuretic peptide, kaliuretic peptide, and atrial natriuretic peptide reduced cancer cells by 97.4%, 87%, 88%, and 89% respectively at 1 mM.
  • These hormones decreased DNA synthesis by 68-89% and were blocked by antibodies, indicating specificity.
  • Natriuretic peptide receptors A and C were identified in prostate cancer cells for the first time.

Conclusions:

  • The anticancer effects of these peptide hormones are specific to prostate cancer.
  • These peptide hormones demonstrate potent efficacy, eliminating up to 97% of prostate cancer cells within 24 hours.
  • The findings suggest a novel therapeutic potential for natriuretic peptides in prostate cancer treatment.